Author

Richard Rosenquist

Karolinska University HospitalORCID 0000-0002-0211-8788Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:whole-genome sequencing· 2 Approach:benchmark study· 1 Assay:bulk RNA-seq· 1 Research Focus:database / resource· 1

Frequent Co-Authors

Aedín C. CulhaneiD· 1 shared Alfonso ValenciaiD· 1 shared Almut LuetgeiD· 1 shared Alyssa C. BouskaiD· 1 shared Anders EdsjöiD· 1 shared Andreas RosenwaldiD· 1 shared Andrew J. GentlesiD· 1 shared Arcangela De NicoloiD· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aedín C. CulhaneORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyNature GeneticsPeer-reviewedMay 1, 2024

The Minimal Dataset for Cancer of the 1+Million Genomes Initiative

Michela Riba, Cinzia Felicita Sala, Aedín C. Culhane…·Giovanni Tonon

The paper develops a standardized data model for cancer genomics to enable interoperable data sharing across countries.

9 citations

whole-genome sequencingbenchmark study

𝕏 PostBluesky

GenomicsbioRxivPreprintApr 16, 2021

Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia

Almut Luetge, Junyan Lu, Jennifer Hüllein…·Thorsten Zenz

This study identifies subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia using RNA-sequencing and genomic data.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky

GenomicsScience Translational MedicinePeer-reviewedJun 19, 2019

Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in the activated B-cell subtype of diffuse large B-cell lymphoma

Neeraj Kumar Jain, Keenan T. Hartert, Saber Tadros…·Michael R. Green

The paper identifies TCF4 overexpression driven by 18q21.2 gains as a mechanism promoting IgM expression in ABC-like DLBCL and shows BET inhibitors can suppress it.

64 citationstop 2%

humanwhole-genome sequencing

𝕏 PostBluesky